Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.61 |
| ▸ | NPC1 | O15118 | 9/20 | 0.61 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.60 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.54 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16920261 | 0.86 | RAB9A (0.63) | RAB9ANPC1SAE1UBA2SMN1; SMN2 | |
| SCHEMBL4105876 | 0.86 | RAB9A (0.63) | RAB9ANPC1SAE1UBA2SMN1; SMN2 | |
| SCHEMBL12711075 | 0.84 | RAB9A (0.77) | RAB9ANPC1SAE1UBA2SMN1; SMN2 | |
| SCHEMBL5852140 | 0.80 | SAE1 (0.76) | RAB9ANPC1SAE1UBA2SMN1; SMN2 | |
| SCHEMBL2722098 | 0.80 | MAPT (0.49) | RAB9ANPC1SMN1; SMN2HPSEKMT2A | |
| SCHEMBL1818695 | 0.79 | NPSR1 (0.61) | RAB9ASMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL10877860 | 0.79 | HPGD (0.53) | RAB9ANPC1KMT2AMEN1HPGD | |
| SCHEMBL28311394 | 0.79 | RAB9A (0.51) | RAB9ANPC1SMN1; SMN2HPSEKMT2A | |
| SCHEMBL22588913 | 0.78 | NPC1 (0.69) | RAB9ANPC1SAE1UBA2SMN1; SMN2 | |
| SCHEMBL9167080 | 0.77 | FAAH (0.54) | RAB9ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10059659-B2 | Enantiomerically pure binaphthol derivatives and method for preparing the same | AMINOLOGICS CO. LTD. (KR) | 2018-08-28 | — | — | US | disclosed |
| EP-2651879-B1 | ENANTIOMERICALLY PURE BINAPHTHOL DERIVATIVES AND METHOD FOR PREPARING THE SAME | AMINOLOGICS CO LTD (KR) | 2018-03-07 | — | — | EP | disclosed |
| US-20140012038-A1 | ENANTIOMERICALLY PURE BINAPHTHOL DERIVATIVES AND METHOD FOR PREPARING THE SAME | AMINOLOGICS CO., LTD. (KR) | 2014-01-09 | — | — | US | disclosed |
| EP-2651879-A2 | ENANTIOMERICALLY PURE BINAPHTHOL DERIVATIVES AND METHOD FOR PREPARING THE SAME | Aminologics Co., Ltd (KR) | 2013-10-23 | — | — | EP | disclosed |
| WO-2012081885-A2 | ENANTIOMERICALLY PURE BINAPHTHOL DERIVATIVES AND METHOD FOR PREPARING THE SAME | AMINOLUX, INC. (KR) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10059659-B2 | Enantiomerically pure binaphthol derivatives and method for preparing the same | ALDH1A1, ALDH7A1, ALDH3A1 | RAB9A 2612/4885NPC1 1105/4885SAE1 1096/4885 |
| US-20140012038-A1 | ENANTIOMERICALLY PURE BINAPHTHOL DERIVATIVES AND METHOD FOR PREPARING THE SAME | ALDH1A1, ALDH7A1, ALDH3A1 | RAB9A 2612/4885NPC1 1105/4885SAE1 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.